OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/01/2026
Voltar para busca
Dado oficial do USPTO
EX'ECRET
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
3, 5, 10
Data de depósito
23/04/2024
Data de registro
22/04/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
22/04/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
KR
Examinador
O'BRIEN, JENNIFER LYNN
Localização atual
Historical data usage
Titulares e representantes
Titulares
HANS PHARMA CO.,LTD.
Representantes
John M. Kim IPLA, LLP
Classificação técnica
Classes Nice
Classe 3Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 3
Functional cosmetics being skin care preparations; anti-aging cosmetic preparationsanti-aging moisturizers; cosmetic preparations for the hair and scalp; moisturizing creamsskin lotions and skin moisturizing gels; body and beauty care cosmetics; non-medicated toiletry preparations; skin lotions; cosmetic preparations for skin care; skin cleansers; essential oils; non-medicated soaps for personal use; facial lotions; facial washes; facial packs as facial beauty masks; perfume; serums for cosmetic purposes; essential oils for cosmetic purposes; cosmetic sun-protecting preparations; make-up removing preparations; cosmetics.
Classe 5
Pharmaceutical preparations for treating chloasma; homeopathic anti-inflammatory ointments; pharmaceutical preparations for activating cellular function; skin lotions for pharmaceutical purposes; ointments for pharmaceutical purposesanti-itch ointments; acne treatment preparations; medicated shampoos; stem cells for medical purposes; medicated lotions for treating dermatological conditions; medicated ointments for treating dermatological conditions; medicated creams for treating dermatological conditions; preparations for cleansing the skin for medical use; pharmaceuticalspharmaceutical preparations for skin care; medicines for human purposesmedicines for treating dermatological conditions for human purposes; injectable dermal fillers; surgical implants comprising living tissuesurgical implants grown from stem cells; gelscreams and solutions for dermatological use; pharmaceutical preparations for treating epidermal problems; pharmaceutical preparations for skin care; skin grafts.
Classe 10
Microdermabrasion apparatus for medical or therapeutic purposes; esthetic massage apparatus; surgical instruments and apparatus; artificial skin for surgical purposes; disposable hypodermic syringes for surgical use; medical apparatus and instruments for use in aesthetic skin treatmentlasers for skin treatment ; lasers for medical purposes; wrinkle removal apparatus for medical purposeslasers for skin treatment; syringes for medical purposes; apparatus for the regeneration of stem cells for medical purposes; skin diagnostic equipment for medical purposesnamely skin diagnostic equipment for the detection of skin disease for medical purposes; medical apparatus for injecting fillersneedle-based and needle-free injection systems and injection devices for pharmaceuticals; automatic medical apparatus for dosing humans by injectionmedical dose meter that measures the total radiation dose received by a patient during a diagnostic procedure; infusion apparatus for therapeutic purposes; artificial biomaterials for augmentation of bone and tissue for dermatology for medical purposes ; esthetic facial massage apparatus for skin whitening effect; medical apparatus for skin wrinkle removallasers for skin treatment; lasers for skin treatment
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
30/12/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
25/12/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
17/12/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
17/12/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/12/2025
FIMP
FINAL DISPOSITION PROCESSED
08/12/2025
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
08/12/2025
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
06/12/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/12/2025
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
31/10/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
23/07/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
22/04/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
22/04/2025
PUBO
PUBLISHED FOR OPPOSITION
04/03/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/03/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/02/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/02/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
06/02/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/02/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
06/02/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/02/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/01/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/01/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/01/2025
RFNT
REFUSAL PROCESSED BY IB
07/12/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
21/11/2024
RFRR
REFUSAL PROCESSED BY MPU
21/11/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
15/11/2024
CNRT
NON-FINAL ACTION WRITTEN
14/11/2024
DOCK
ASSIGNED TO EXAMINER
06/11/2024
MAFR
APPLICATION FILING RECEIPT MAILED
26/07/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
26/07/2024
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
25/07/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
18/07/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EX'ECRET ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.